This study tests a new gel called **ENERGI-F703** to help heal diabetic foot ulcers, which are open sores on feet of people with diabetes. The study is **Phase 3**, meaning it's one of the last steps before the gel could be approved for general use. People with ulcers graded as **Wagner Grade 1 or 2** (mild to moderate severity) can join. They will be split into two groups: one gets the gel, and the other gets a non-active gel, with neither knowing which they receive.

The study lasts up to **31 weeks**: 2-3 weeks for initial checks, 16 weeks for treatment, and 12 weeks for follow-up. Participants must be at least 18, have diabetes, and have a foot ulcer that hasn't healed in at least 4 weeks. The ulcer should not be infected or have dead tissue.

• Participants need to visit the clinic multiple times over the 31 weeks.
• Participants will be randomly assigned to a group and won't know which treatment they receive.
• Participants must agree to use birth control if they are of childbearing potential.